A diabetes outcome progression trial (ADOPT): an international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes.

A diabetes outcome progression trial (ADOPT): an international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes.

Show other versions (1)

OBJECTIVE: Therapies with metformin, sulfonylureas, or insulin improve glycemic control in the short term but do not prevent progressive islet beta-cell failure or long-term deterioration in glycemia. Our goal was to evaluate, in patients recently diagnosed with type 2 diabetes (<3 years), t...

Full description

Bibliographic Details
Main Authors: Viberti, G, Kahn, SE, Greene, D, Herman, W, Zinman, B, Holman, R, Haffner, S, Levy, D, Lachin, J, Berry, R, Heise, M, Jones, N, Freed, M
Format: Journal article
Language:English
Published: 2002

Similar Items

Similar Items